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Concussion is difficult to diagnose, particularly when symptoms are atypical or late in
presenting. An accurate and timely initial assessment is crucial for clinical management.
Cerebral spinal fluid (CSF) and blood markers of traumatic brain injury show promising
results but their clinical applicability in concussion has significant limitations. In the study,
we explored saliva as a new source of biomarkers of concussion. Saliva samples of
concussed players were collected after 48–72 h from concussion and analyzed by high-
throughput technologies. A discovery group of 10 concussed rugby professional and
semiprofessional athletes and 10 non-concussed matched controls was used for the
analysis of 92 inflammatory proteins by the Proseek-Multiplex-Inflammation technology.
In addition, saliva samples of 6 concussed and 6 non-concussed athletes were used
to screen 800 human microRNAs (miRNAs) by the Nanostring Technology. The results
were then validated by RT-qPCR in an enlarged cohort (validation group) comprising 22
concussed athletes. Results showed, no significant variations of the 65 inflammatory
proteins detected in saliva between groups but 5 microRNAs, miR-27b-3p (p = 0.016),
let-7i-5p (p = 0.001), miR-142-3p (p = 0.008), miR-107 (p = 0.028), miR-135b-5p
(p = 0.017) significantly upregulated in concussed athletes. Univariate ROC curve
analysis showed that the differentially expressed miRNAs could be considered good
classifiers of concussion. Further analyses showed significant correlation between these
microRNAs and Reaction Time component of the ImPACT concussion assessment tool.
In addition, biocomputation analysis predicted the involvement of these microRNAs in
important biological processes that might be related to trauma, such as response to
hypoxia, cell death, neurogenesis, axon repair and myelination. Ease of access and
non-invasiveness of saliva samples make these biomarkers particularly suitable for
concussion assessment.
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INTRODUCTION
There is growing concern that we may be facing a “concussion
epidemic” in sport, military and recreational activities in general
with significant associated unrecognized morbidity. Concussion,
or mTBI (Harmon et al., 2013) can be defined as a transient
impairment of neurological function after mechanical injury and
affects up to 3.8 million participants in sports of all kind in the
United States alone (Maroon et al., 2014). However, this injury
is also common in the military (DeKosky et al., 2010) and has
been described as the signature injury of the recent conflicts in
Afghanistan and Iraq. The true incidence of mTBI is difficult
to establish and is likely to be far greater than reported figures
because type of injury is routinely under-recognized, trivialized
and under-reported. This is partially due to the spontaneous
resolution of symptoms in most patients even in the absence of
medical care.
However, many studies have demonstrated that individuals
who sustain one concussion are potentially more susceptible than
others, especially if the new injury occurs before the symptoms
from the previous concussion have completely resolved (Tavazzi
et al., 2007; Vagnozzi et al., 2007, 2008). Importantly, repeated
concussion is associated with depression (Vos et al., 2017)
and chronic neurodegenerative conditions in later life, e.g.,
Parkinson’s disease, motor neuron disease and CTE (Omalu,
2014; Gaetz, 2017).
One of the main challenges faced by medical practitioners
is the lack of objective parameters to support the diagnosis
of concussion and guide return-to play-decisions following the
injury (McCrory et al., 2017).
Currently, the vast majority of concussion assessment tools
are indirect measures of the response to trauma. A concussion
does not typically cause structural injury to the brain, thus
neuroimaging tests such as MRI scan or CT scans are used
primarily to rule out a more serious injury, but are not able to
exclude the presence of mTBI currently.
Over the last few years, the measurement of biomarkers in
biofluids has received growing attention. Serum/plasma and CSF
are most studied biofluids, but it is possible that some central
nervous system (CNS)-derived proteins are eventually excreted
into body fluids other than CSF and blood. The presence of
the axonal protein Tau in saliva, for example, was demonstrated
using mass spectrometry (Shi et al., 2011). In addition, the same
research group has also detected Parkinson-related α-synuclein
and DJ-1 in this body fluid (Devic et al., 2011).
Abbreviations: AUC, area under the curve; BBB, brain–blood barrier; CNS,
central nervous system; CSF, cerebral spinal fluid; CTE, chronic traumatic
encephalopathy; DE-miRNAs, differentially expressed microRNAs; FDA, food and
drug administration; FDR, false discovery rate; GFAP, glial fibrillary acid protein;
GMN, global median normalization; GO, gene ontology; ImPACT, Immediate
Post-Concussion Assessment and Cognitive Testing; KEGG, Kyoto encyclopedia
of genes and genomes; miRs or miRNAs, microRNAs; mTBI, mild traumatic
brain injuries; NAB, neuropsychological assessment battery; NFL, neurofilament
light; NPX, normalized protein expression units; POC, point-of-care; ROC,
operating characteristic; SAM, significance of microarrays analysis; SCAT3, sport
concussion assessment tool; TBI, traumatic brain injuries; T-tau, Total tau; UCHL-
L1, ubiquitin carboxyl-terminal esterase L1; WAIS-IV, Wechsler Adult Intelligence
Scale-Fourth Edition.
However, the relationship between salivary concentrations of
these proteins and processes within the CNS is far from clear
and no conclusive data on disease association have been reported
so far.
Saliva is an important physiologic fluid, containing a highly
complex mixture of substances, and is rapidly gaining interest
for novel approaches to diagnosis, prognosis and management
of patients with either oral or systemic diseases. In addition, it
is easily collected and stored, and is ideal for POC devices.
In this study, we sought to identify saliva biomarkers from
a well-characterized cohort of contact sport-professional and
semiprofessional athletes with a view to developing a non-
invasive, objective test to support clinical decision-making in
sport and military medicine.
MATERIALS AND METHODS
Study Approval
Study participants were recruited through the Surgical
Reconstruction and Microbiology Research Centre (SRMRC),
based at Queen Elizabeth Hospital of Birmingham
(United Kingdom), as part of the ReCoS (The REpetitive
COncussion in Sport). This study was carried out in accordance
with the recommendations of the University of Birmingham
Research Ethics Committee. The protocol was approved by that
same ethical committee together with peer review by the National
Institute of Health Research Centre for Surgical, Reconstruction
and Microbiological Research Centre (NIHR SRMRC – Ethics
Ref. 11-0429AP28). All subjects gave written informed consent
in accordance with the Declaration of Helsinki.
Male athletes aged 16–65 years, participating in professional
and semi-professional Rugby who have been positively diagnosed
as having a concussion along with a normal neurological
objective examination at assessment, were enrolled in this
study. Individuals who require hospital admission after initial
assessment for their TBI, presenting intracranial blood, brain
tissue injury, or non-TBI related pathologies on initial CT/MR
scan, any history of neurodegenerative pathology or history of
chronic alcohol or drug abuse were excluded. In addition, age
matched controls, who have not received any concussion in the
previous 3 months, were recruited.
Sample Collection
Saliva samples from a total of 20 subjects (discovery group)
were analyzed. In particular, saliva samples of 10 concussed
and 10 non-concussed athletes were used to screen proteins
and 6 concussed and 6 non-concussed athletes for microRNA
analysis. Saliva of concussed players was collected 48–72 h after
a concussion, certified by the attending enhanced care team
in accordance with the current protocol for the relevant sport,
was confirmed. Samples from the non-concussed players were
collected at rest before the training sessions. The athletes would
not have done strenuous exercise since the day before at least.
From these data, we calculated the sample size needed for
validation in a larger cohort of patients with alpha = 0.05 and
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power = 0.9. The sample size required was 29 subjects based on
the most variant miRNA identified in the discovery group.
A second set of samples (validation group) was obtained from
a total of 22 concussed and 10 non-concussed players. Samples
were collected at the same time point.
Clinical, demographic (Table 1), neuropsychometric and
imaging parameters were collected for each subject including,
among others, parameters forming part of the SCAT3 (e.g.,
symptoms inventory, injury data, balance errors and immediate
memory and recall tests), concussion history, the ImPACT
(approved computerized neuropsychometric suite for sport
concussion), and the WAIS-IV symbol search.
Saliva samples were also collected from an additional group
consisting of 12 concussed athletes at later time points (>120 h).
Sample Processing
Five ml of saliva were collected in a 50 ml sterile plastic universal
container tube kept on ice for no more than 30′. Samples were
then centrifuged at 2600 × g for 15′ at 4◦C. Saliva was then
divided into aliquots and to each ml of saliva, 1 ml aprotinin
(stock 10 mg/ml), 3 ml Na3VO4 (stock 400 mM) and 10 ml PMSF
(stock 10 mg/ml) was added for the analysis of 92 inflammatory
proteins. RNase inhibitor (500 units/mL) was added for the
analysis of miRNAs.
Samples were stored at−80◦C until analysis.
Proximity Extension Assay
The Proseek Multiplex Inflammation I (Olink Bioscience,
Uppsala, Sweden) was used to perform the multiplex proximity
assay according to the manufacturers protocol (Olink Bioscience,
Uppsala, Sweden). Briefly, 1 µl of human saliva together with 3 µl
of mix containing antibodies labeled with corresponding DNA
oligonucleotides was incubated over night at 8◦C. Following
this, 96 µl of extension mix containing proximity extension
assay enzymes and PCR reagents were added. Following a 5′
incubation plates were placed on the thermal cycler for 17 cycles
of DNA amplification. The 96.96 Dynamic Array IFC (Fluidigm,
CA, United States) was primed according to the manufacturer’s
instructions. In a separate plate, 7.2 µl of detection mix and
2.8 µl of samples were mixed together and from this, 5 µl was
loaded into the primed 96.96 Dynamic Array IFC. The specific
primer pairs for the 92 inflammatory proteins (Supplementary
Table S1) were loaded into the 96.96 dynamic array and the
protein expression program activated in the Fluidigm Biomark
reader as per Proseek instructions. Further details about detection
limits, reproducibility and validations can be found at the Olink
webpage1.
Data Analysis
Data were transferred from the Biomark reader to Olink Wizard
for GenEx software (Olink). From there, presented as NPX on
a linear scale with high NPX corresponding to high protein
concentration. Data were checked for normal distribution and
t-test analysis was performed to compare the two groups
(concussed vs. non-concussed athletes). Finally, p-values were
1https://www.olink.com/
adjusted for multiple testing through the False Discovery Rate
method of correction (FDR).
RNA Isolation
Total RNA was isolated from 400 µl of saliva by using
Qiagen miRNeasy Mini Kit (Qiagen, GmbH, Hilden, Germany),
according to Qiagen Supplementary Protocol for purification of
RNA (including small RNAs) from serum or plasma (Ragusa
et al., 2015). Finally, RNA was eluted in 200 µl RNAse-free
water and subsequently precipitated by adding 20 µg glycogen,
0.1 volumes 3 M sodium acetate and 2.5 volumes ice cold
100% ethanol. After incubation at −80◦C overnight, RNA was
centrifuged and washed twice in ice cold 75% ethanol and
resuspended in 7 µl RNAse-free water. RNA was quantified using
a NanoDrop R© ND-1000 spectrophotometer (Thermo Scientific,
Wilmington, DE, United States). An Agilent 2100 Bioanalyzer
(Santa Clara, CA, United States) was used to detect the size
distribution of total RNA, as well as determine the quality of
the RNA. .
Circulating miRNA Profiling Through
NanoString Technology
Expression profile of miRNAs from saliva was performed
through NanoString technology by using nCounter Human v3
miRNA Expression Assay Kits (NanoString Technologies) in an
nCounter FLEX (Prep Station and Digital Analyzer) (NanoString
Technologies), according to manufacturer instructions. Profiling
was performed on 6 concussed and 6 non-concussed athletes.
Three µl (approximately 150 ng) of total RNA were used for
sample preparation. Data analysis was performed through
nSolver 2.6 software. nCounter “normalized counts” were
obtained from the raw counts from each hybridization
normalized to the internal positive controls (to account for
slight differences in assay efficiencies), and to three most stable
reference miRNAs (to account for RNA amount differences),
according to nSolver analysis software protocol. MiRNAs used
as endogenous controls were selected through GMN method: we
computed Pearson correlation between the count means for each
lane and the counts of each miRNA, identifying those miRNAs
whose expression was closer to the count mean of the cartridge
(miR-23a-3p, miR-29b-3p, and miR-148b-3p) (Cirnigliaro
et al., 2017). Statistical analysis was performed through SAM2,
using a p-value based on 100 permutations; imputation engine:
K-nearest neighbors (10 neighbors); FDR< 0.05.
Heat map of expression profiles was generated by plotting
the fold changes calculated as the ratio between the normalized
counts of each sample and the mean of normalized counts of
all samples. By using Multi Experiment Viewer (MeV 4.9), we
generated the sample clustering through hierarchical clustering
approach by selecting Manhattan distance metric.
Single TaqMan Assays
Twenty-one differentially expressed miRNAs were chosen from
the arrays as potential candidate biomarkers of concussion. These
2http://www.tm4.org
Frontiers in Molecular Neuroscience | www.frontiersin.org 3 August 2018 | Volume 11 | Article 290
fnmol-11-00290 August 17, 2018 Time: 10:20 # 4
Di Pietro et al. Salivary miRs, Biomarkers of Concussion
TABLE 1 | Clinical and demographic characteristic of the study subjects included in the analysis of microRNA.
Study Number of Age Gender Days elapsed Number of total
group samples from concussion professional career
concussions
Mean SD Range M/F Mean SD Range Mean SD Range
Discovery
group
Controls 6 30 3.8 (22–33) 6/0 13.3 14.5 (0–5)
Concussion 6 24.5 2.5 (21–28) 6/0 2.8 0.4 (2–3) 9.6 12.9 (0–4)
Validation
Group
Controls 10 25.3 2.6 (20–28) 10/0 1.4 1.3 (0–4)
Concussion 22 23.3 3.4 (17–31) 22/0 3.5 1.4 (2–5) 3.4 2 (0–8)
candidates were used to validate the data in an enlarged cohort of
22 concussed athletes and 10 non-concussed athletes (validation
group). Saliva was analyzed by single TaqMan assays (Applied
Biosystems, Life TechnologiesTM). Samples were extracted as
described above, retrotranscribed (Applied Biosystems, Life
TechnologiesTM) and RT-qPCR analysis was performed in a
Bio-Rad iQ5 Real-time PCR Detection System (Bio-Rad, CA,
United States). Expression fold changes were calculated by the
2−11CT method by using miR-23a-3p and miR-148b-3p as
reference genes.
miRNA Target Computational Analysis
We retrieved the experimentally validated targets of the Taqman
confirmed DE-miRNAs (differentially expressed miRNA) from
Tarbase3 and miRTarbase4 by selecting data just from highly
confident experiments (e.g., luciferase or immunoprecipitation
assays). We considered for downstream analysis all targets from
both tools. Gene ontology enrichment of these targets was
computationally analyzed by using FatiGo tool from Babelomics
4 suite5 and DAVID Bioinformatics Resources 6.86. Statistical
over-representation was calculated by using Fisher’s exact test;
Benjamini and Hochberg FDR Correction; p ≤ 0.05. The
outputs of these analyses were compared and we reported just
the matching gene ontologies. The tissue abundance of DE
miRNAs was analyzed by screening the Human miRNA tissue
atlas7.
ImPACT and WAIS-IV Tests
The ImPACT test was designed in the early 1990s to assess
concussed players of the National Football League (Maroon et al.,
2014).
Nowadays, it is one of the most commonly used FDA
(food and drug administration) approved neurocognitive tests in
sport concussion (Covassin et al., 2009). The ImPACT includes
a medical history and self-reported concussion symptoms
questionnaire and neurocognitive tests. The neurocognitive tests
are divided into six modules. The results of these modules
score the following parameters: verbal memory, visual memory,
3http://carolina.imis.athena-innovation.gr/diana_tools/web/index.php
4http://mirtarbase.mbc.nctu.edu.tw
5babelomics.bioinfo.cipf.es
6https://david.ncifcrf.gov
7https://ccb-web.cs.uni-saarland.de/tissueatlas/
visual-motor processing speed, reaction time and impulse
control. The results are shown as row score and percentile.
In the analysis of the data, age, gender, learning disability
and level of education are taken into consideration. Another
test to measure the cognitive abilities is the WAIS-IV. The
WAIS-IV is compound of 10 tasks. Among these, the symbol
search has demonstrated utility in the assessment of mTBI.
Here, participants have to identify identical symbols in two
rows within 2 min and errors of commission and omission are
included to form a composite score. The NAB is a widely utilized
clinically validated set of tests in TBI management. The digit span
and reverse digit span numerical memory assessments are key
components of this. These two tests give information regarding
processing speed and working memory, respectively.
Statistical Analysis
A non-parametric test (Mann–Whitney U test) was used to
compare the level of miRNAs in the two independent groups.
A p-value< 0.05 was accepted as significant.
In addition, a Receiver Operating Characteristic (ROC)
analysis was utilized to calculate sensitivity and specificity of
each biomarker in diagnosing concussion, expressed as AUC.
Multivariate ROC curve was calculated by using MetaboAnalyst8.
Using a Spearman correlation analysis miRNA levels were also
correlated with age, ImPACT and WAIS-IV.
An additional test was applied to compare miRNA expression
at different time points, 48–72 h and >120 h, of concussed
athletes with non-concussed athletes. The data were checked
for normal distribution and transformed to perform parametric
tests. Comparisons across groups at each time were performed
by the one-way analysis of variance and Tukey’s post hoc test on
transformed data.
All statistical analyses were carried on SPSS v.22 (IBM).
RESULTS
Proseek Multiplex Analysis
92 human proteins were analyzed in saliva samples using the
Proseek Multiplex Inflammation I panel. All samples met the
quality control criteria and 65 of the 92 analyzed proteins
were detected in all saliva samples. t-Test was applied for
8http://www.metaboanalyst.ca/
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proteins detected and results showed no proteins significantly
and differentially expressed between two groups. Volcano plot
is represented in Figure 1. A full list of the 65 proteins
detected in saliva together with fold changes and standard
deviations among groups is also presented in Supplementary
Table S2.
Nanostring Profiling
Among the 800 microRNAs analyzed by nCounter NanoString in
saliva of concussed and non-concussed athletes, 21 miRNAs were
selected as differentially expressed across the two populations:
hsa-let-7c-5p, hsa-let-7i-5p, hsa-miR-15b-5p, hsa-miR-16-5p,
hsa-miR-20a-5p+hsa-miR-20b-5p, hsa-miR-24-3p, hsa-miR-
27b-3p, hsa-miR-29a-3p, hsa-miR-29c-3p, hsa-miR-30a-5p,
hsa-miR-107, hsa-miR-135b-5p, hsa-miR-142-3p, hsa-miR-
148a-3p, hsa-miR-181a-5p, hsa-miR-199b-5p, hsa-miR-221-3p,
hsa-miR-324-5p, hsa-miR-424-5p e hsa-miR-652-3p. Results
showed a significant upregulation for all the miRNAs mentioned
above.
A heat-map is represented in Figure 2.
FIGURE 1 | Volcano plot of salivary inflammatory proteins. The volcano plot visualizes the p-value (y-axis) and difference in NPX (x-axis) for all 65 analyzed proteins.
Proteins on the positive x-axis have higher NPX-values in the non-concussed group and proteins on the negative x-axis have higher NPX-values in the concussed
group. The solid line indicates an unadjusted p-value of 0.05 and the dashed line indicates approximated adjusted p-value (FDR) of 0.05.
FIGURE 2 | Heat-map of DE-miRNAs in saliva of concussed and non-concussed athletes. Heat-map of the miRNAs differentially expressed in saliva of concussed
and non-concussed athletes. The values of log2 fold changes for each miRNA are color coded, as shown in the colored bar. Sample clustering obtained through
hierarchical clustering approach is shown. NC, non-concussed athletes; C, concussed athletes.
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Single TaqMan Assay
In order to validate these findings, we subsequently tested
the expression of the 21 selected miRNAs in a separate and
independent group, composed of 22 concussed athletes and
10 matched non-concussed athletes. Among these candidate
biomarkers for concussion, 5 were significantly upregulated in
the validation group. Specifically, miR-27b-3p (p = 0.016), let-
7i-5p (p = 0.001), miR-142-3p (p = 0.008), miR-107 (p = 0.028),
miR-135b-5p (p = 0.017) confirmed the results obtained by
Nanostring analysis (Figure 3). AUCs for miR-27b-3p (AUC,
0.755; 95% CI, 0.575–0.934), let-7i-5p (AUC, 0.845; 95% CI,
0.681–1), miR-142-3p (AUC, 0.791; 95% CI, 0.634–0.948), miR-
107 (AUC, 0.732; 95% CI, 0.565–0.904), miR-135b-5p (AUC,
0.755; 95% CI, 0.573–0.936) are shown in Figure 4. We computed
four models of multivariate ROC curves, each one built on
a combination of 2, 3, 4, or 5 DE miRNAs, respectively,
and compared their AUCs (Figure 5). The “5 miRNA” model
showed the highest AUC: 0.836 (CI: 0.669–0.995). However,
the comparison among confusion matrixes of univariate curves
and “5 miRNA” model curve did not show an improvement
of diagnostic performance for multivariate ROC curve, thus
confirming let-7i-5p as the best performing biomarker of mTBI
(Table 2).
MiRNA Targets and Gene Ontology
Analysis
The different distribution of these miRNAs in saliva of concussed
athletes is most likely a systemic consequence of the different
physiopathology of this typology of trauma. In order to evaluate
the biological functions of DE-miRNAs, we computationally
searched their validated or predicted targets. Gene ontologies and
pathway associations of miRNA targets were analyzed by FatiGo
and DAVID. This analysis showed that they could be involved in
important biological processes related to trauma (i.e., response
to hypoxia, cell death, neurogenesis, axon repair, myelination)
(Figure 6). By screening the Human miRNA tissue atlas, we
found that all validated DE-miRNAs, with exclusion of miR-142-
3p, were expressed in almost all body tissues, but more abundant
in brain (Supplementary Figure S1).
Sperman Correlation Analysis and Paired
Comparisons With Neuropsychometric
Tests
A summary of the ImPACT and WAIS data obtained from the
concussed and non-concussed groups is illustrated in Table 3.
Sperman correlation analysis showed a positive relationship
FIGURE 3 | Boxplot of the 5 candidate miRNA biomarkers. Boxplot of relative expression of the five microRNAs which showed a significant upregulation (p < 0.05)
in the validation group and assessed by RT-PCR. A non-parametric test (Mann–Whitney U test) was used to compare the level of microRNAs in the two independent
groups.
Frontiers in Molecular Neuroscience | www.frontiersin.org 6 August 2018 | Volume 11 | Article 290
fnmol-11-00290 August 17, 2018 Time: 10:20 # 7
Di Pietro et al. Salivary miRs, Biomarkers of Concussion
FIGURE 4 | Area under the curve of the five candidate miRNA biomarkers.
Receiver-operating characteristic (ROC) curve and corresponding area under
the curve (AUC) for biomarkers identified in the validation cohort.
between the ImPACT reaction time percentile and the level of
microRNA let-7i-5p (R, 0.49; FRD 0.02) and miR-27b-3p (R,
0.52; FDR 0.02). In addition an inverse correlation was detected
between the level of miR-135b-5p and the number of concussions
(R,−0.48; FDR 0.05) (Figure 7).
No statistically significant difference was seen in the ImPACT
cognitive efficiency index (summary composite score of all sub
domains), or WAIS symbol search score (Mann–Whitney U,
p = 0.54 and 0.204, respectively) between the concussed and
non-concussed group.
Single TaqMan Assay at Later Time
Points
In order to assess the progress or decline of the selected
miRNAs at later time points from concussion, we subsequently
tested the expression of the 5 selected miRNAs in a separate
and independent group, comprising 12 concussed athletes.
Expression changes were compared with early concussed athletes
(48–72 h) and non-concussed athletes. Results showed in
Supplementary Figure S2 confirmed a p-value < 0.05 between
the non-concussed athletes and concussed athletes at early time
points. Specifically, miR-27b-3p (p = 0.053), let-7i-5p (p = 0.014),
miR-142-3p (p = 0.028), miR-107 (p = 0.015), miR-135b-5p
(p = 0.042).
An additional significant result was found in the fold change of
let-7i-5p (p = 0.036) between concussed athletes early time point
(48–72 h) and concussed athletes later time point (>120 h). No
others significant results were found across the groups.
DISCUSSION
Despite the millions of sports-related concussions that occur
annually, currently there are no available and sufficiently sensitive
molecular-biomarkers to make a clear diagnosis of concussion, to
predict recovery and an athlete’s readiness to return to play.
Among the most studied T-tau, NFL in CSF (Hesse et al.,
2000; Nylen et al., 2006; Zetterberg et al., 2006; Neselius et al.,
2012), S-100β, GFAP and its breakdown products, and UCHL-
L1 in plasma/serum, but their utility in the diagnosis of mild to
moderate TBI is still unknown (Vos et al., 2010; Brophy et al.,
2011; Papa et al., 2012a,b; Thelin et al., 2013; Di Pietro et al., 2015)
and in the majority of the cases their use is limited to alteration of
BBB (Zetterberg et al., 2013).
Areas under curve of the most studied protein biomarkers
in TBI are presented in Supplementary Table S3 as previously
reported by Di Pietro et al. (2018).
In this study, we examined saliva, a novel fluid for discovering
new biomarkers within this context. The potential of saliva as a
biomarker of mTBI has been increasingly recognized in recent
years (Hicks et al., 2018; Johnson et al., 2018). A variety of
molecular and microbial analytes (Aas et al., 2005; Park et al.,
2006; Bonne and Wong, 2012) have been identified in saliva
and considering that salivary glands are highly permeable and
enveloped by capillaries, these molecules have the potential
to mirror the blood content and diagnose systemic disorders
(Burbelo et al., 2012).
Our results showed for the majority of the detected
salivary proteins, a moderate but not statistically significant
downregulation in concussed athletes. We would interpret this
as a programmed shut-down of the synthesis of proteins that
are not required following injury but the interplay between
different cellular pathways makes the interpretation somewhat
speculative. However, this downregulation is in agreement with
our previous findings (Di Pietro et al., 2013). In this previous
study, we were able to demonstrate, using an in vitro stretch
model of mild TBI, that mTBI triggers a controlled gene program
and a hypometabolic state, as an adaptive response finalized to
neuroprotection, similar to that found in hibernators and in
ischemic preconditioning.
On the contrary, our results show a different and significant
expression of microRNAs in the two groups. MiRNAs are a quite
recently discovered class of non-coding RNAs, which plays key
roles in the regulation of gene expression. They are found in every
human tissue and biofluid, are resistant to RNAse degradation
and have the ability to cross the BBB (Fire et al., 1998; Chan et al.,
2005; Lim et al., 2005; Gauthier and Wollheim, 2006; Bi et al.,
2009; Friedman et al., 2009; Li and He, 2012; Szafranski et al.,
2015).
MiRNAs are attracting increasing interest in clinical research
as potential biomarkers for the detection, identification and
classification of cancers and other disease states including
neurodegenerative diseases and most recently, brain trauma
(Redell et al., 2010; Vallelunga et al., 2014; Ragusa et al., 2016,
2017; Di Pietro et al., 2017).
The 5 upregulated microRNAs found in this study, are not
brain-specific but they are also expressed in other tissues such
as heart, kidney, or testis, as described in two studies aimed
to build comprehensive human miRNA tissue atlas catalog
and annotating accurate sequence, expression and conservation
information for the large number of recently proposed miRNAs
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FIGURE 5 | Multivariate ROC Curve analysis. (A) Four models of multivariate ROC curves, each one built on a combination of 2, 3, 4, or 5 DE miRNAs. (B) Five
miRNA model ROC curve with confidence intervals highlighted in blue. (C) Sample classification plot and confusion matrix generated from the five miRNA model
ROC curve.
TABLE 2 | Comparison of performances of univariate and multivariate ROC curves.
let-7i-5p miR-142-3p miR-107 miR-27b-3p miR-135b-5p Multivariate
Sensitivity 0.8636 0.7273 0.6818 0.6818 0.7273 0.7273
Specificity 0.1 0.2 0.1 0.3 0.2 0.1
Precision 0.6786 0.6667 0.625 0.6818 0.6667 0.64
Negative predictive value 0.25 0.25 0.125 0.3 0.25 0.1429
False positive rate 0.9 0.8 0.9 0.7 0.8 0.9
False discovery rate 0.3214 0.3333 0.375 0.3182 0.3333 0.36
False negative rate 0.1364 0.2727 0.3182 0.3182 0.2727 0.2727
Accuracy 0.625 0.5625 0.5 0.5625 0.5625 0.5313
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FIGURE 6 | Pathway enrichment analysis of miRNAs. Over-represented biological functions of let-7i-5p, miR-27b-3p, miR-142-3p, miR-107, miR-135b-5p
computed by analyzing their validated molecular targets through FatiGo and David tools. On the left of the histogram are reported the over represented pathways,
while, on the right the corresponding p-values of Fisher’s Exact Test. On the x-axis are reported the percentages of gene targets associated to biological functions.
TABLE 3 | A summary of ImPACT (percentile score with regard to all ImPACT test takers) and WAIS data.
ImPACT domain
percentile
Verbal
memory
Visual
memory
Motor
speed
Reaction
time
Symptoms
score
Cognitive
efficiency index
WAIS symbol
search score
Mean/Median
Concussed 59.8%/67% 48%/47% 54.6%/55.5% 55.6%/72.5% 18.8%/4% 0.41%/0.4% 37.1/36.5
Non-concussed 11%/72.5% 69.4%/66.5% 50.9%/57% 41.1%/38% 2.63%/1% 0.26%/0.3% 39.1/40
(Landgraf et al., 2007; Ludwig et al., 2016). However, 2 of them
were described in the context of TBI as potential biomarkers in
other biofluids. In particular, miR-27b was described in serum
(Bhomia et al., 2016) and CSF (Yang et al., 2016) and miR-142-
3p was identified in plasma of patients mildly injured and at
greater risk of developing amnesia and therefore, post-concussive
syndromes (Mitra et al., 2017).
In addition, other animal studies have described the
involvement of these miRs in TBI research.
MiR-27b was found overexpressed in mouse neurons,
inhibiting neuronal apoptosis induced by intrauterine
hypoxia (Chen et al., 2014). MiR-27a was also found rapidly
downregulated in injured cortex and this change coincided with
increased expression of the proapoptotic Bcl-2 family members
such as Noxa, Puma, and Bax (Sabirzhanov et al., 2014).
MicroRNA let-7i was found in both serum and cerebrospinal
fluid immediately after blast wave exposure. In addition, this
miRNA plays a role in the regulatory pathways of several
inflammatory cytokines and therefore and ideal candidate
biomarkers in TBI (Balakathiresan et al., 2012).
Finally, miR-107 regulates granulin/progranulin with
implications for traumatic brain injury and neurodegenerative
disease (Wang et al., 2010).
According to our results two miRNAs, let-7i-5p and miR-27b-
3p, positively correlate with the ImPACT reaction time percentile.
This finding suggests that these miRNAs contribute to the process
of recovery, enabling natural mechanisms of neuroprotection
(Balakathiresan et al., 2012; Chen et al., 2014; Sabirzhanov et al.,
2014) rather than providing a biomarker of biological damage.
Interestingly, no information is available about the function of
miR-135b-5p, which is negatively correlated with the number of
concussions. Further studies will be required to further elucidate
the nature and mechanisms of this miRNA in mTBI. Notably,
we found a general upregulation of miRNAs in mTBI patients:
we could speculate that the increased release of glutamate
observed after concussion can induce an excitatory stimulus on
parasympathetic neurons that innervate the submandibular and
sublingual salivary glands (Mitoh et al., 2004; Guerriero et al.,
2015). This should lead to an increased saliva secretion and,
theoretically, to a similar effect on miRNA release.
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FIGURE 7 | Sperman correlation of the 5 candidate miRNA biomarkers with neurocognitive assessment tools. Spearman R-values depict correlations between
salivary concentrations of the 5 miRNAs of interest and the indexes of ImPACT test and WAIS symbol search and digit span results. Boxes highlight correlations
between miRNA levels and clinical indexes which are statistically significant (p < 0.05). Values highlighted with black borders show the statistically significant
(p < 0.05) correlations between miRNA levels and clinical indexes.
The fact that neither our concussed or non-concussed cohort
had statistically different scores in the ImPACT of WAIS
assessment may potentially indicate that levels of expressed
miRNAs may serve as a more sensitive test to resolve a concussive
event. Although possibly useful within the clinical management
of concussion, multiple publications have demonstrated that
these assessments have significant limitations when used in
isolation to diagnose/resolve a concussive event (Schatz et al.,
2006; Broglio et al., 2007).
Finally, the computational analysis of the present study
identified that miRNAs contribute to multiple CNS processes,
such as neurogenesis, and axon repair and myelination, providing
evidence for further link miRNAs to mechanisms that are widely
associated with concussion symptoms and recovery. Incidentally,
the comparison among the whole set of inflammatory proteins
studied and targets of five DE-miRNAs, showed only about
5% overlap. This may suggest that molecular circuits regulated
by DE-miRNAs are quite unrelated to classical inflammation
pathways.
Univariate ROC curves showed a good diagnostic accuracy
for all the five miRNAs identified in this study, supporting
the potential use of these biomarkers in clinical decision-
making in sport and military medicine. Specifically, the goal of
using miRNA biomarkers would be to detect mTBI with the
highest possible accuracy, and a single biomarker often could
be not sufficient. For this reason, the use of a combination
of biomarkers is preferable, as it should increase diagnostic
accuracy. However, by using a multivariate ROC curve model
considering all the 5 miRNAs, we did not observe a significant
improvement of diagnostic performances with respect to the
univariate ROC curves. The comparison of performances of
all classification models showed that let-7i-5p is the best
classifier.
In conclusion, this study explored a suite of salivary miRNA
based biomarkers for diagnosis of concussion. Five biomarkers
were identified with potential utility to distinguish concussed
athletes from non-concussed athletes after 48–72 h from injury.
In addition, preliminary results of later time points (>120 h),
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showed that these miRs are not able to discriminate concussed
from non-concussed athletes.
STUDY LIMITATIONS
Several limitations of this study must be considered.
In the first instance, the lack of miRNA validation. Only 5
of the 21 miRs selected in the discovery study, which means
<25% of candidates, were confirmed in the validation cohort
of the 22 athletes analyzed. This can be due to several factors;
the sample size for example, although partially justified with the
power analysis, is smaller than existing microRNA studies (Di
Pietro et al., 2017; Johnson et al., 2018). Secondly, cohort of
patients was enrolled within a broad sampling time window (48–
72 h), which represents a long interval considering the biological
mechanism of microRNAs and their role as molecular regulators.
In addition, we are not aware if miRNA expression varies at
specific conditions such as: fasting or circadian rhythm.
Currently, the majority of the studies on miRNA biomarkers,
reports the comparison between miRNAs identified in patients
and in healthy controls without testing other factors that impact
the miRNA abundance. For this reason, the evaluation of miRNA
biomarkers in terms of stability and variability in a population
of individuals without known diseases, remains one of the main
challenges. Thus, variable markers can only be used if there
are substantial differences in the signal between affected and
unaffected individuals.
Another limitation of the study is that long-term outcome
including return to play data and chronic symptomatology
in these patients was not collected. Finally, we do not know
how soon these biomarkers became upregulated in saliva after
concussion.
Further research, including an earlier and detailed time of
collection together with an enlarged group of study and a
comparison with internal controls such as within the same
subjects before and after concussion, or with orthopedic injury
population and an additional study showing microRNA variation
after exercise, is needed in order to aid the diagnosis of
concussion in the treatment room, clinic and possibly pitch-side.
However, the most important finding showed in this paper,
is that saliva miRNA outperforms saliva protein for identifying
mTBI and provides support for the idea that peripheral
microRNA patterns hold promise where years of protein
biomarker work have fallen.
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